Old Web
English
Sign In
Acemap
>
authorDetail
>
Jan Tebbe
Jan Tebbe
Bayer HealthCare Pharmaceuticals
Molecular biology
Antibody
Immunology
Medicine
Chemistry
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Conjugués homogènes spécifiques au site avec inhibiteurs de ksp
2016
Hans-Georg Lerchen
Yolanda Cancho Grande
Beatrix Stelte-Ludwig
Anette Sommer
Christoph Mahlert
Anne-Sophie Rebstock
Simone Greven
Nils Griebenow
Jan Tebbe
Oliver Kensch
Show All
Source
Cite
Save
Citations (0)
Characterization of a High-Affinity Fully Human IgG2 Antibody Against Tissue Factor Pathway Inhibitor As a Bypass Agent for the Treatment of Hemophilia
2015
Blood
Maxine Bauzon
Bing Liu
Joanna Grudzinska-Goebel
Jan Tebbe
Junliang Pan
Jill Cifrese
Zhuozhi Wang
Derek Sim
Show All
Source
Cite
Save
Citations (1)
Abstract 5445: Preclinical anti-tumor efficacy of an anti-C4.4a (LYPD3) antibody drug conjugate for the treatment of lung squamous cell carcinoma
2014
Cancer Research
Joerg Willuda
Lars Linden
Hans-Georg Lerchen
Charlotte Kopitz
Sven Golfier
Ute Bach
Joachim Schumacher
Beatrix Stelte-Ludwig
Oliver von Ahsen
Claudia Schneider
Frank Dittmer
Rudolf Beier
Sherif El-Sheik
Jan Tebbe
Gabriele Leder
Heiner Apeler
Rolf Jautelat
Bertolt Kreft
Karl Ziegelbauer
Show All
Source
Cite
Save
Citations (0)
Anticorps anti-fgfr2 et utilisations de ceux-ci
2012
Axel Harrenga
Charlotte Kopitz
Stefanie Hammer
Frank Dittmer
Sven Golfier
Mark Trautwein
Sandra Bruder
Jürgen Franz
Beatrix Stelte-Ludwig
Lars Linden
Ricarda Finnern
Simone Greven
Jan Tebbe
Show All
Source
Cite
Save
Citations (0)
1